Acquisition Momentum Arithmos has recently expanded through the May 2026 acquisition of Epiqure, a move that broadens GxP quality assurance, compliance, and technology capabilities. This signals potential for cross-sell across regulatory, PV, and quality domains to Epiqure’s existing clients and a faster entry into new life sciences accounts.

Healthcare Focus With a dedicated emphasis on life sciences R&D, clinical research, quality assurance, drug safety, and regulatory affairs, Arithmos presents a compelling value proposition for pharma, biotech, and contract research organizations seeking end-to-end process optimization powered by technology and validation.

Tech Stack Leverage Utilizing platforms like Salesforce, SAS, Oracle, and Zoho alongside collaboration tools, Arithmos can offer integrated data, analytics, and workflow improvements to customers adopting digital transformation. This enables targeted upsell on data management, compliance reporting, and process automation.

Industry Events Active participation in global events such as World Patient Safety Congress, Veeva R&D and Quality Summit, CDISC Europe Interchange, and QA conferences indicates a proactive sales approach. This creates opportunities to engage prospects early, showcase joint PV quality offerings, and generate qualified leads.

Growth Tier Fit Revenue range and employee count place Arithmos alongside specialized mid-market players. This aligns with sales motions targeting mid-sized pharma and life sciences services firms seeking strategic partners for compliance, quality, and digital transformation without enterprise-scale constraints.